Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-11,828
Closed -$174K 497
2025
Q3
$174K Buy
11,828
+2,053
+21% +$20.9K 0.05% 313
2025
Q2
$96K Sell
9,775
-11,137
-53% -$92.2K 0.03% 348
2025
Q1
$152K Buy
+20,912
New +$183K 0.04% 325

Other funds holding ETNB

Virtus Investment Advisers's ETNB Position: Q4 2025 in Review

Virtus Investment Advisers sold out of 89bio (ETNB) in Q4 2025, closing a stake of 11,828 shares — an estimated $174K sold.

Virtus Investment Advisers first reported a position in ETNB in Q1 2025 and held it in 3 quarters. The position peaked at $174K in Q3 2025. 2 funds tracked by Wall St. Rank hold ETNB as of Q4 2025.

  • Virtus Investment Advisers reported no remaining 89bio position as of Q4 2025 after selling out during the quarter.
  • Virtus Investment Advisers sold 11,828 89bio shares in Q4 2025, an estimated $174K.
  • Virtus Investment Advisers first reported a position in 89bio in Q1 2025 and held it in 3 quarters.
  • Virtus Investment Advisers's 89bio position peaked at $174K in Q3 2025.
  • 2 funds tracked by Wall St. Rank held 89bio as of Q4 2025.

Based on Virtus Investment Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.